BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thanapirom K, Teerasarntipan T, Treeprasertsuk S, Choudhury A, Sahu MK, Maiwall R, Pamecha V, Moreau R, Al Mahtab M, Chawla YK, Devarbhavi H, Yu C, Ning Q, Amarapurkar D, Eapen CE, Hamid SS, Butt AS, Kim DJ, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Yuen MF, Chan A, Lau G, Jia J, Rahman S, Sharma BC, Yokosuka O, Sarin SK; APASL ACLF Working Party. Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure. Hepatol Int 2021. [PMID: 34822057 DOI: 10.1007/s12072-021-10266-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Chu J, Yang Y, Liu Y, Pei L, Zhou Y, Lu T, Zhang Y, Hu H, Li Y, Yang F, Lin S. Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares. Infect Dis Ther 2022. [PMID: 36151452 DOI: 10.1007/s40121-022-00695-9] [Reference Citation Analysis]
2 Chon HY, Ahn SH, Kim YJ, Yoon JH, Lee JH, Sinn DH, Kim SU. Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients. Hepatol Int 2021;15:1328-36. [PMID: 34799838 DOI: 10.1007/s12072-021-10262-y] [Reference Citation Analysis]